Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Capitol Health.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: GDP drama is over, now markets brace for the lack of drama, drama
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Goldman recommends these two ASX stocks in the booming diagnostic imaging space
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer
Experts
Finding the next ASX growth stock, with Martin Hickson from 1851 Capital
News
Half-Yearlies Top 5: Locality Planning Energy is today’s top performer
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
News
Trading Places: Which ASX shares have institutional investors been buying over January?
News
Rise and Shine: What you need to know before the ASX opens
News
Trading Places: Here are this week’s substantial holder movements
News
Corporate: Capitol Health commits $16m to buying South Australian musculoskeletal imaging provider
Experts
Money Talks: These diagnostic imaging plays paint a pretty picture for investors
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
Health & Biotech
Integral profit down, revenue up; tells shareholders to keep ignoring takeover
Health & Biotech
Battle of the funds heats up as Team Integral launches war of words
Health & Biotech
